Firebrick Pharma Ltd (FRE)

Sydney
Currency in AUD
0.07
0.00(0.00%)
Closed·
FRE Scorecard
Full Analysis
Impressive gross profit margins
FRE is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.070.08
52 wk Range
0.050.10
Key Statistics
Edit
Bid/Ask
0.07 / 0.08
Prev. Close
0.07
Open
0.08
Day's Range
0.07-0.08
52 wk Range
0.05-0.1
Volume
22.43K
Average Volume (3m)
55.26K
1-Year Change
18.64%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
FRE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Firebrick Pharma Ltd News & Analysis

Show more

Firebrick Pharma Ltd Company Profile

Firebrick Pharma Limited engages in the development and commercializing of novel formulations for the uses of povidone iodine in Australia. The company offers broad-spectrum antimicrobial nasal spray for the treatment of common cold under the Nasodine name. It also operates in the United states and Singapore. Firebrick Pharma Limited was incorporated in 2012 and is based in Melbourne, Australia.

Compare FRE to Peers and Sector

Metrics to compare
FRE
Peers
Sector
Relationship
P/E Ratio
−9.1x−5.1x−0.5x
PEG Ratio
−0.140.000.00
Price/Book
10.5x1.6x2.6x
Price / LTM Sales
13.9x9.5x3.1x
Upside (Analyst Target)
-139.4%50.4%
Fair Value Upside
Unlock19.6%8.7%Unlock

Earnings

Latest Release
Feb 20, 2025
EPS / Forecast
-0.01 / --
Revenue / Forecast
197.07K / --
EPS Revisions
Last 90 days

FRE Income Statement

FAQ

What Is the Firebrick Pharma (FRE) Stock Price Today?

The Firebrick Pharma stock price today is 0.07

What Stock Exchange Does Firebrick Pharma Trade On?

Firebrick Pharma is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Firebrick Pharma?

The stock symbol for Firebrick Pharma is "FRE."

What Is the Firebrick Pharma Market Cap?

As of today, Firebrick Pharma market cap is 16.17M.

What Is Firebrick Pharma's Earnings Per Share (TTM)?

The Firebrick Pharma EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is FRE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Firebrick Pharma Stock Split?

Firebrick Pharma has split 0 times.

How Many Employees Does Firebrick Pharma Have?

Firebrick Pharma has 0 employees.

What is the current trading status of Firebrick Pharma (FRE)?

As of 13 June 2025, Firebrick Pharma (FRE) is trading at a price of 0.07, with a previous close of 0.07. The stock has fluctuated within a day range of 0.07 to 0.08, while its 52-week range spans from 0.05 to 0.10.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.